Outcome of ICU treatment in invasive aspergillosis

Intensive Care Medicine

Volumn 22, Issue 12, 1996, Pages 1315-1322

  Janssen, J J W M ^a   Strack Van Schijndel, R J M ^a   Van Der Poest Clement, E H ^a   Ossenkoppele, G J ^a   Thijs, L G ^a   Huijgens, P C ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Aspergillosis; Intensive care; Respiratory failure

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCYTOSINE; ITRACONAZOLE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLOSIS; CLINICAL ARTICLE; FEMALE; HUMAN; INTENSIVE CARE; MALE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0030444622     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01709544     Document Type: Article

References (31)

1. Denning DW, Stevens DA (1990) Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 12: 1147-1201
2. Karam GH, Griffin FM (1986) Invasive pulmonary aspergillosis in nonimmunosuppressed, non-neutropenic hosts. Rev Infect Dis 8: 357-363
3. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Apache II: a severity of disease classification system. Crit Care Med 13: 818-829
4. Fisher BD, Armstrong D, Yu B, Gold JWM (1981) Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med 71: 571-577
5. Schuster DP, Marion JM (1983) Precedents of meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy. Am J Med 75: 402-408
6. Estopa R, Marti AT, Kastanos N, Rives A, Agusti-Vidal A, Rozman C (1984) Acute respiratory failure in severe hematologic disorders. Crit Care Med 12: 26-28
7. Ewer MS, Ali MK, Atta MS, Morice RC, Balakrishnan PV (1986) Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure. JAMA 256: 3364-3366
8. Saugier-Veber P, Devergie A, Sulahian A, Riband P, Traore F, Bourdeau-Esperou H et al. (1993) Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5-year retrospective study. Bone Marrow Transplant 12: 121-124
9. Peters SG, Meadows JA, Gracey DR (1988) Outcome of respiratory failure in hematologic malignancy. Chest 94/1: 99-102
10. Crawford SW, Petersen FB (1992) Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis 145: 510-514
11. Poe RH, Wahl GW, Qazi R, Kallay MC, Utell MJ, Morrow GR (1986) Predictors of mortality in the immunocompromised patient with pulmonary infiltrates. Arch Intern Med 146: 1304-1308
12. Crawford SW, Schwartz DA, Petersen FB, Clark JC (1988) Risk factors of mechanical ventilation after marrow transplantation. Am Rev Respir Dis 137: 682-687
13. Faber-Langedoen K, Caplan AL, McGlave PB (1993) Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant 12: 501-507
14. Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ (1988) Prognosis of patients receiving intensive care for life-threatening medical complications of haematological malignancy. BMJ 296: 1025-1029
15. Yau E, Rohatiner AZS, Lister TA, Hinds CJ (1991) Long term prognosis and quality of life following intensive care for life-threatening complications of haematologic malignancy. Br J Cancer 64: 938-942
16. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG (1992) Outcome of recipients of bone marrow transplants who require intensive care unit support. Mayo Clin Proc 67: 117-122
17. Gillespie DJ, Marsh HMM. Divertie MB, Meadows JA III (1986) Clinical outcome of respiratory failure in patients requiring prolonged (> 24 hours) mechanical ventilation. Chest 90 3: 364-369
18. Denardo SJ, Oye RK, Bellamy PE (1989) Efficacy of intensive care for hone marrow transplant patients with respiratory failure. Crit Care Med 17: 4-6
19. McCabe RE, Brooks RG, Mark JBD, Remington JS (1985) Open lung biopsy in patients with acute leukemia. Am J Med 78: 609-616
20. Yu VL, Muder RR, Poorsattar A (1986) Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 81: 249-254
21. Nalesnik MA, Myerowitz, Jenkins R, Lenkey J, Herbert D (1980) Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 11: 370-376
22. Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA (1984) Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 76: 1027-1034
23. Stover DE, Zaman MB, Hajdu SI, Lange M, Gold J, Armstrong D (1984) Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med 101: 1-7
24. Tang CM, Holden DW, Aufavre-Brown A, Cohen J (1993) The detection of Aspergillus spp. by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid. Am Rev Respir Dis 148: 1313-1317
25. Schulze-Berge A, Sonntag H-G, Kappe R (1994) Evaluation of seven commercially available serodiagnostic tests for invasive aspergillosis. J Infect 28 (Suppl 1): 57-58
26. Denning DW, Tucker RM, Hanson LH, Stevens DA (1989) Treatment of invasive aspergillosis with itraconazole. Am J Med 86: 791-800
27. Denning DW (1994) Treatment of invasive aspergillosis. J Infect 28 (Suppl 1): 25-33
28. NIAID Mycoses Study Group (1994) Multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 97: 135-144
29. Hay RJ (1994) Liposomal amphotericin B, AmBisome. J Infect 28 (Suppl 1): 35-43
30. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk LJ, Cassileth PA (1984) Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Int Med 100: 345-351
31. Working party of the British Society for Antimicrobial Chemotherapy (1993) Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. J Antimicrob Chemother 32: 5-21